Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatology Emergencies in Skin of Colour Patients.

British journal of hospital medicine (London, England : 2005)·2026
Same author

Methods to assess uncertainties in doses arising from internal contamination with plutonium: Bayesian statistics and hyper-realisations.

Radiation and environmental biophysics·2025
Same author

Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20.

The British journal of dermatology·2025
Same author

Challenges in the diagnosis and management of psoriatic arthritis in people of colour.

Rheumatology (Oxford, England)·2025
Same author

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.

The Lancet. Rheumatology·2024
Same author

Resilience and active inference.

Frontiers in psychology·2023

Related Experiment Video

Updated: May 19, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Morphoea with myositis: a rare association.

Mary Sommerlad1, Richard Bull, Claire Gorman

  • 1Department of Rheumatology, Homerton University Hospital, London E9 6SR, UK.

Case Reports in Rheumatology
|September 1, 2012
PubMed
Summary

This case study highlights a rare instance of morphoea (localized scleroderma) followed by atypical myositis in a young woman. This previously undescribed association expands our understanding of connective tissue disease presentations.

Related Experiment Videos

Last Updated: May 19, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Background:

  • Morphoea, a form of localized scleroderma, typically presents with skin induration.
  • Myositis, an inflammatory muscle disease, is often associated with systemic sclerosis.
  • The co-occurrence of morphoea and myositis is not well-documented in medical literature.

Observation:

  • A young woman presented with a skin rash characteristic of morphoea, confirmed by biopsy.
  • Following the morphoea diagnosis, she developed myositis affecting muscles in an unusual pattern.
  • The distribution of myositis was atypical and not previously associated with localized scleroderma.

Findings:

  • This case details the first reported instance of myositis developing in the context of morphoea.
  • The findings suggest a potential, albeit rare, link between localized scleroderma and inflammatory myopathy.
  • Biopsy confirmed both morphoea and the subsequent myositis.

Implications:

  • This case expands the spectrum of potential complications associated with morphoea.
  • It prompts consideration of myositis in patients with morphoea, particularly with atypical symptoms.
  • Further research may elucidate the underlying mechanisms connecting localized scleroderma and myositis.